FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024397914> ?p ?o ?g. }

• W2024397914 endingPage "256" @default.
• W2024397914 startingPage "250" @default.
• W2024397914 abstract "Alemtuzumab (anti-CD52, Campath-1H) has recently been shown to be effective in the treatment of a range of hematological malignancies, including B-cell chronic lymphocytic leukemia and T-cell prolymphocytic leukemia. We undertook a phase II study to evaluate the safety, tolerability and efficacy of alemtuzumab in patients with relapsed or refractory advanced stage cutaneous T-cell lymphoma.A total of eight patients were enrolled, seven with mycosis fungoides/Sézary syndrome (MF/SS) and one with large-cell transformation of MF. Seven patients had disease refractory to multiple previous therapies. Alemzumab (30 mg) was administered intravenously three times per week for 12 wk or until maximum response.The overall response rate was 38%, with three patients achieving partial remission, two patients with stable disease and three patients with progressive disease (PD) during treatment. The time to progression was short, with all patients developing PD within 4 months of starting alemtuzumab. Response duration in the three PR patients was also brief, with responses lasting less than 3 months in all three cases. Significant hematological and immunosuppressive toxicity was observed, with both grade 3-4 cytopenias and significant infectious complications occurring in a majority of cases.Our findings suggest that in heavily pretreated, refractory, advanced stage MF/SS, although alemtuzumab has biological activity, it is associated with significant toxicity and only modest clinical utility. As such, combination regimens incorporating alemtuzumab merit further investigation in this difficult to treat patient group." @default.
• W2024397914 created "2016-06-24" @default.
• W2024397914 creator A5001557317 @default.
• W2024397914 creator A5031193094 @default.
• W2024397914 creator A5037352082 @default.
• W2024397914 creator A5051174375 @default.
• W2024397914 creator A5059028953 @default.
• W2024397914 creator A5081326206 @default.
• W2024397914 creator A5081838635 @default.
• W2024397914 creator A5090867545 @default.
• W2024397914 date "2003-09-01" @default.
• W2024397914 modified "2023-09-26" @default.
• W2024397914 title "Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab" @default.
• W2024397914 cites W1506762754 @default.
• W2024397914 cites W1749229087 @default.
• W2024397914 cites W1833241997 @default.
• W2024397914 cites W1895474562 @default.
• W2024397914 cites W1954038871 @default.
• W2024397914 cites W1959866484 @default.
• W2024397914 cites W1974738881 @default.
• W2024397914 cites W1987203409 @default.
• W2024397914 cites W1988679162 @default.
• W2024397914 cites W1989053318 @default.
• W2024397914 cites W1989716470 @default.
• W2024397914 cites W2006103885 @default.
• W2024397914 cites W2015421929 @default.
• W2024397914 cites W2016373265 @default.
• W2024397914 cites W2016776292 @default.
• W2024397914 cites W2019274594 @default.
• W2024397914 cites W2024627032 @default.
• W2024397914 cites W2027423329 @default.
• W2024397914 cites W2028415674 @default.
• W2024397914 cites W2035249021 @default.
• W2024397914 cites W2045733649 @default.
• W2024397914 cites W2064796513 @default.
• W2024397914 cites W2066803563 @default.
• W2024397914 cites W2076105499 @default.
• W2024397914 cites W2089790910 @default.
• W2024397914 cites W2091145111 @default.
• W2024397914 cites W2104041885 @default.
• W2024397914 cites W2108276207 @default.
• W2024397914 cites W2115782311 @default.
• W2024397914 cites W2141127880 @default.
• W2024397914 cites W2149367896 @default.
• W2024397914 cites W2168799171 @default.
• W2024397914 cites W2169167811 @default.
• W2024397914 cites W233460929 @default.
• W2024397914 cites W4243059760 @default.
• W2024397914 cites W74992319 @default.
• W2024397914 cites W83807906 @default.
• W2024397914 doi "https://doi.org/10.1034/j.1600-0609.2003.00143.x" @default.
• W2024397914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12950233" @default.
• W2024397914 hasPublicationYear "2003" @default.
• W2024397914 type Work @default.
• W2024397914 sameAs 2024397914 @default.
• W2024397914 citedByCount "131" @default.
• W2024397914 countsByYear W20243979142012 @default.
• W2024397914 countsByYear W20243979142013 @default.
• W2024397914 countsByYear W20243979142014 @default.
• W2024397914 countsByYear W20243979142015 @default.
• W2024397914 countsByYear W20243979142016 @default.
• W2024397914 countsByYear W20243979142017 @default.
• W2024397914 countsByYear W20243979142018 @default.
• W2024397914 countsByYear W20243979142019 @default.
• W2024397914 countsByYear W20243979142020 @default.
• W2024397914 countsByYear W20243979142021 @default.
• W2024397914 countsByYear W20243979142022 @default.
• W2024397914 crossrefType "journal-article" @default.
• W2024397914 hasAuthorship W2024397914A5001557317 @default.
• W2024397914 hasAuthorship W2024397914A5031193094 @default.
• W2024397914 hasAuthorship W2024397914A5037352082 @default.
• W2024397914 hasAuthorship W2024397914A5051174375 @default.
• W2024397914 hasAuthorship W2024397914A5059028953 @default.
• W2024397914 hasAuthorship W2024397914A5081326206 @default.
• W2024397914 hasAuthorship W2024397914A5081838635 @default.
• W2024397914 hasAuthorship W2024397914A5090867545 @default.
• W2024397914 hasConcept C121332964 @default.
• W2024397914 hasConcept C126322002 @default.
• W2024397914 hasConcept C141071460 @default.
• W2024397914 hasConcept C142424586 @default.
• W2024397914 hasConcept C197934379 @default.
• W2024397914 hasConcept C2777756187 @default.
• W2024397914 hasConcept C2777938653 @default.
• W2024397914 hasConcept C2778375690 @default.
• W2024397914 hasConcept C2778384904 @default.
• W2024397914 hasConcept C2778461978 @default.
• W2024397914 hasConcept C2779015954 @default.
• W2024397914 hasConcept C2779338263 @default.
• W2024397914 hasConcept C2911091166 @default.
• W2024397914 hasConcept C71924100 @default.
• W2024397914 hasConcept C87355193 @default.
• W2024397914 hasConcept C90924648 @default.
• W2024397914 hasConceptScore W2024397914C121332964 @default.
• W2024397914 hasConceptScore W2024397914C126322002 @default.
• W2024397914 hasConceptScore W2024397914C141071460 @default.
• W2024397914 hasConceptScore W2024397914C142424586 @default.
• W2024397914 hasConceptScore W2024397914C197934379 @default.
• W2024397914 hasConceptScore W2024397914C2777756187 @default.

• next